Immuneering Corporation Class A Common Stock (NASDAQ: IMRX) last traded at $3.94, up 5.35% on the session. The quote above updates while this page is open; the figures below are drawn from Immuneering Corporation Class A Common Stock’s own filings and are restated only when a new one is published.
Immuneering Corporation Class A Common Stock trades on NASDAQ under the ticker IMRX. Its market capitalisation is $254.91 million.
Valuation measures for Immuneering Corporation Class A Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $254.91M |
|---|---|
| Enterprise value | $224.90M |
| Price / book | 1.34 |
| Beta | 1.15 |
Trailing-twelve-month figures tagged in Immuneering Corporation Class A Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$57.28M |
| EPS (TTM) | -$0.930 |
|---|
| Return on equity | -30.03% |
|---|
| Cash | $41.32M |
|---|
Range and volume for IMRX over the past 52 weeks.
| 52-week high | $8.48 |
|---|---|
| 52-week low | $3.60 |
| Volume | 709.7K |
| Average volume | 708.1K |
| Previous close | $3.74 |
Invest a chosen dollar amount in Immuneering Corporation Class A Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell IMRX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.